IP Group (LON:IPO) Share Price Passes Above 200 Day Moving Average – Should You Sell?

Shares of IP Group Plc (LON:IPO) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 57.35 and traded as high as GBX 62.80. IP Group shares last traded at GBX 62.39, with a volume of 1,601,431 shares.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on IPO shares. Deutsche Bank Aktiengesellschaft increased their price objective on IP Group from GBX 103 to GBX 110 and gave the stock a “buy” rating in a report on Wednesday, March 18th. Berenberg Bank restated a “buy” rating and issued a GBX 100 target price on shares of IP Group in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 105.

IP Group Price Performance

The stock has a market capitalization of £553.03 million, a price-to-earnings ratio of 8.82 and a beta of 1.21. The company has a quick ratio of 8.59, a current ratio of 0.16 and a debt-to-equity ratio of 12.28. The business has a 50-day simple moving average of GBX 54.74 and a two-hundred day simple moving average of GBX 57.35.

IP Group (LON:IPO) last released its earnings results on Tuesday, March 17th. The company reported GBX 7.24 earnings per share for the quarter. IP Group had a return on equity of 7.16% and a net margin of 3,526.32%. As a group, research analysts predict that IP Group Plc will post 19.6245031 earnings per share for the current fiscal year.

IP Group Company Profile

IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK’s largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach.